Boehringer Ingelheim

Description

As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development, and delivery of our products to our patients and customers. Our global presence provides opportunities for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the companies' success. We realize that our strength and competitive advantage lie with our people. We support our employees in several ways to foster a healthy working environment, meaningful work, mobility, networking, and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees.

The Vice President Early Clinical Development, Experimental Medicine – Therapeutic Area (TA) Oncology within BI’s Innovation Unit (IU) will provide strategic and visionary leadership for early clinical development and global experimental medicine within the TA. This VP role is critical to accelerating First-in-Men studies to proof-of-concept studies, shaping global disease area and therapeutic modality strategy, and ensuring competitive differentiation of our compounds. This role will drive innovation and scientific and operational excellence to integrate cutting edge translational science, influence portfolio decisions, and deliver high quality clinical data sets to accelerate smart development of transformative therapies aligned with corporate objectives.

The VP, Experimental Medicine – TA Oncology has enterprise-wide impact through portfolio acceleration, external scientific leadership, planning and execution excellence and cross-functional integration with regulatory, clinical operations, and commercial strategies globally.

Duties & Responsibilities

Strategic Leadership:

• Defines and executes global medical/clinical and translational strategy for the TA
• Serves as a key decision-maker in governance committees
• Responsible for timely delivery of early-phase clinical plans in alignment with compound and overall portfolio strategy
  
  
  

Scientific & Clinical Excellence:

• Oversees design and conduct of First-in-Men to Proof-of-Concept studies (e.g. Phase I–IIb) ensuring scientific rigor and regulatory compliance
• Maintains deep knowledge of emerging science and competitor strategies
• Oversees alignment of scientific platforms, medical communication, and product optimization plans
• Reviews and approves protocols, reports, and publications
  
  
  

Team Leadership:

• Builds and inspires high-performing global teams, including clinical scientists, medical directors, biomarker experts and other early clinical development functions
• Fosters innovation and operational excellence
  
  
  

Cross-Functional Collaboration:

• Partners with Research, Safety Science, Clinical Pharmacology, Translational Medicine, Regulatory, and Commercial teams
• Responsible for effective governance participation; stakeholder satisfaction
  
  
  

Business Development & External Engagement:

• Leads preliminary clinical evaluations for in-licensing opportunities
• Represents the organization externally with key opinion leaders and regulatory authorities
  
  
  

Requirements

• MD or MD/PhD in relevant medical specialty/Therapeutic Area required, e.g. board-certification in medical oncology, hematology, or other relevant organ specialty
• Scientific Expertise: Deep understanding of disease biology, clinical trial design, and translational medicine (biomarker and companion diagnostic strategy)
• Advanced clinical and scientific expertise in Clinical Oncology and Translational Oncology Research, with focus on early clinical development (IND through Proof of Concept)
• Clinical specialization or board eligibility in respective Therapeutic Area
• 10–15 years of combined experience across hospital, academic, and industry settings, including senior leadership roles; U.S. clinical/pharma experience strongly preferred
• Proven ability to influence enterprise-level decisions and deliver strategic impact in a global matrix organization
• Leadership: Ability to inspire and lead multidisciplinary and crossfunctional teams
• Strategic Thinking: Strong capability to define and execute long-term vision
• Communication: Excellent ability to influence and engage internal and external stakeholders
• Regulatory Knowledge: Familiarity with global drug development and compliance requirements
• Innovation: Track record of implementing novel approaches in early clinical development
  
  
  

Compensation:

 This position, VP, Experimental Medicine - Oncology, offers a base salary typically between $280,000.00 and $441,000.00.  The position may be eligible for a role specific variable or performance based bonus and or other compensation elements. For an overview of our benefits please click here.

Eligibility Requirements:

• Must be legally authorized to work in the United States without restriction
• Must be willing to take a drug test and post-offer physical (if required)
• Must be 18 years of age or older
  
  
  

Desired Skills, Experience And Abilities

Our Company

Why Boehringer Ingelheim?

With us, you can develop your own path in a company with a culture that knows our differences are our strengths - and break new ground in the drive to make millions of lives better.

Here, your development is our priority. Supporting you to build a career as part of a workplace that is independent, authentic and bold, while tackling challenging work in a respectful and friendly environment where everyone is valued and welcomed.

Alongside, you have access to programs and groups that ensure your health and wellbeing are looked after - as we make major investments to drive global accessibility to healthcare. By being part of a team that is constantly innovating, you'll be helping to transform lives for generations.

Want to learn more? Visit https://www.boehringer-ingelheim.com